Development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung

PneumoNP is a collaborative research program funded under the Seventh Framework Programme, with a €5.7 million grant. Starting in 2014, it is aiming at the development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung, with focus on Klebsiella pneumoniae caused infections.

 
 

Latest news from PneumoNP

7_ECCMID_Vienna 2017 picture-logo_480x310

Meet us at ECCMID 2017

PneumoNP partners will attend ECCMID 2017 in Vienna, Austria, from 22-25th April 2017. ECCMID is a major event for experts ...
Read More
P.R.I.T.® air-liquid interface system principle and setup for the PneumoNP project

The P.R.I.T.® lung model to test nanoparticle-based drugs

The German technology P.R.I.T.® with its air-liquid interface imitates lung behaviour. It is used for the first time to test ...
Read More